Her-2/neu and EGFR tyrosine kinase activation predict the...

Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer

Gernot Hudelist, Wolfgang J. Köstler, Klaus Czerwenka, Ernst Kubista, Johannes Attems, Ruth Müller, Daphne Gschwantler-Kaulich, Mahmood Manavi, Isabell Huber, Heinz Hoschützky, Christoph C. Zielinski,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
118
Year:
2006
Language:
english
Pages:
9
DOI:
10.1002/ijc.21492
File:
PDF, 372 KB
english, 2006
Conversion to is in progress
Conversion to is failed